Hormonal
PT-141
Bremelanotide, Melanocortin Agonist
Scientific Overview
PT-141, also called bremelanotide, is a cyclic peptide in the melanocortin agonist family, chemically related to melanotan research sequences. Indexed literature discusses it as a melanocortin-receptor ligand.
Mechanism focus: Pharmacology papers describe melanocortin-receptor agonism with a profile distinct from linear alpha-MSH fragments. This catalog page stays with receptor research and does not state clinical outcome claims.
Research Use Cases
- Melanocortin receptor pharmacology
- Cyclic peptide structure-activity research
- Central melanocortin signaling models
- Analytical comparison with related melanocortin peptides
Use-Case Study Notations
- Case-study notation: drug-monograph and approval literature indexes bremelanotide as a melanocortin agonist.
- Case-study notation: safety summaries across the clinical development program are published separately from receptor-assay papers.
- Related melanotan II is a different cyclic melanocortin peptide. The two are not the same material.
Selected Studies (English, PubMed)
Three peer-reviewed sources indexed on PubMed. Links open the PubMed record for verification.
- Bremelanotide — PubMed 34436837
- Bremelanotide: First Approval — PubMed 31429064
- Safety Profile of Bremelanotide Across the Clinical Development Program — PubMed 35147466
Related compounds
Research Use Only. This page is educational and intended for laboratory research context. Products are not for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.